US Patent 7498141 Assay system for GLP-2 receptor ligands

Patent 7498141 was granted and assigned to Nps Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Nps Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7498141

Date of Patent

March 3, 2009

Patent Application Number

11607030

Date Filed

December 1, 2006

Patent Primary Examiner

‌

Robert Landsman

Patent abstract

Disclosed herein is a method for measuring the contractility of intestinal tissue upon treatment with GLP-2 or a GLP-2 ligand. Also disclosed is an assay which directly measures the activity of GLP-2 or GLP-2 ligands ex vivo and permits the screening of putative GLP-2 ligands in native tissue.